Latest Strategy Changes News

AVITA Medical reported an 18% revenue increase in Q3 2025 driven by new product launches and deeper market penetration, while continuing to face net losses and credit covenant challenges. The company also announced a CEO departure and interim leadership appointment.

AVITA Medical reported a 13% revenue decline in Q3 2025 but improved cash efficiency and secured Medicare payment confirmations for RECELL®, positioning for growth in 2026.

AVITA Medical reported a 13% drop in Q3 commercial revenue to $17.1 million but improved its net loss and secured CE Mark approval for RECELL GO in Europe, signaling strategic shifts ahead.

Mount Hope Mining Limited launches a $1.25 million Share Purchase Plan at $0.20 per share, matching a recent placement, to fund drilling and land acquisitions at its Mount Hope Project.

oOh!media reports a 7% revenue increase in Q3 2025, slightly ahead of prior guidance, but flags challenges from a key New Zealand contract loss and softer advertising demand in October.

Aurum Resources reports strong high-grade gold intercepts from its extensive drilling program at the Boundiali Gold Project in Côte d’Ivoire, boosting resource confidence ahead of major updates in early 2026.

Tanami Gold NL has updated its Central Tanami Project Mineral Resource Estimate, boosting total gold resources to 2.8 million ounces. This increase reflects recent drilling, higher gold price assumptions, and improved metallurgical recoveries across multiple deposits.

Macquarie Group Limited reported a 3% increase in net profit to A$1.655 billion for the half year ended 30 September 2025, driven by robust performances in its asset management and capital segments. The Group’s diversified funding and strong capital position underpin its strategic growth and climate finance initiatives.

Macquarie Bank Limited reported a robust half-year profit of AUD 3.67 billion, up 61% from the prior period, driven by strategic asset sales and strong loan growth. The bank’s capital position remains solid amid ongoing investments in technology and risk management.

Macquarie Group Limited reported a 3% increase in half-year profit to $1.655 billion, driven by growth across its asset management, banking, commodities, and capital markets divisions. The group maintains robust capital and liquidity positions despite margin pressures and regulatory challenges.

MedAdvisor Limited has appointed John Ciccio as its new CEO and Managing Director, marking a strategic leadership shift aimed at capitalising on recent technology advancements and US market growth.

Macquarie Group reported a solid half-year profit increase despite a sequential dip, boosted by strong asset management and capital markets performance. The group also extended its share buyback and declared a steady interim dividend.